Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,178 | 9,703 | 4,739 | 5,965 | 7,006 |
| Receivables | 2,003 | 1,452 | 673 | 1,234 | 1,024 |
| Inventories | 545 | 589 | 482 | 505 | 514 |
| Other current assets | 28 | 6 | 48 | 98 | 12 |
| TOTAL | $12,136 | $12,454 | $6,827 | $7,840 | $8,927 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 242 | 13 | 53 |
| TOTAL | $N/A | $N/A | $242 | $13 | $53 |
| Total Assets | $12,136 | $12,454 | $7,069 | $7,853 | $8,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,184 | 1,954 | 1,712 | 1,397 | 1,415 |
| Accrued Expenses | 2,287 | 2,003 | 2,936 | 830 | 613 |
| TOTAL | $9,471 | $8,957 | $9,648 | $2,241 | $2,081 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 5,000 | 5,000 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,486 | 1,360 |
| TOTAL | $N/A | $N/A | $N/A | $6,486 | $6,360 |
| Total Liabilities | $9,471 | $8,957 | $9,648 | $8,727 | $8,441 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 735 | 716 | 706 | 278 | 278 |
| Common Shares | 0 | 1 | 0 | 0 | 0 |
| Retained earnings | -126,287 | -125,019 | -123,439 | -121,452 | -119,758 |
| TOTAL | $2,665 | $3,497 | $-2,580 | $-874 | $538 |
| Total Liabilities And Equity | $12,136 | $12,454 | $7,069 | $7,853 | $8,980 |